Skip to main content
Log in

Acquisition of syncytium-inducing HIV-1 strains during therapy with zidovudine alone or combined with alpha interferon or didanosine

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The effect of antiretroviral treatment on HIV-1 phenotype was studied in a group of 83 nucleoside-naive patients. These initially nonsyncytium-inducing HIV-1 positive patients were followed prospectively for their HIV-1 phenotype. Syncytium-inducing variants were detected by cocultivation of peripheral blood mononuclear cells with the MT-2 T-cell line. Overall, 16 of 83 (19%) patients underwent a shift to syncytium-inducing phenotype: 11 of 67 during zidovudine treatment, 3 of 10 during zidovudine plus alpha interferon treatment, and 2 of 6 under initial zidovudine plus didanosine therapy. The results of this study demonstrate that neither zidovudine therapy alone nor combined with interferon or didanosine prevents the acquisition of syncytium-inducing strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Koot M, Keet IPM, Vos AHV, De Goede REY, Ross MTL, Coutinho RA, Miedema F, Schellekens PTA, Tersmette M: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Annals of Internal Medicine 1993, 118: 681–688.

    PubMed  Google Scholar 

  2. Buckheit RW, Germany-Decker J, Quails-Goodwin K, Bowdon BJ, Shannon WM: 3′-azido-3′-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation. Proceedings of the National Academy of Sciences of the USA 1992, 89:8361–8365.

    PubMed  Google Scholar 

  3. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD: A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus. Journal of Infectious Diseases 1993, 168: 1374–1379.

    PubMed  Google Scholar 

  4. Boucher CAB, Lange JMA, Miedema F, Weverling GJ, Koot M, Mulder JW, Goudsmidt J, Kellam P, Larder BA, Tersmette M: HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS 1992, 6: 1259–1264.

    PubMed  Google Scholar 

  5. Koot M, Schellekens PTA, Mulder JW, Lange JMA, Roos MTL, Coutinho RA, Tersmette M, Miedema F: Viral phenotype and T cell reactivity in human immunodeficiency virus type 1 -infected asymptomatic men treated with zidovudine. Journal of Infectious Diseases 1993, 168:733–736.

    PubMed  Google Scholar 

  6. Leal M, Torres Y, Medrano FJ, Calderon EJ, Rey C, Lissen E: Does early zidovudine treatment prevent the emergence of syncytium-inducing human immunodeficiency virus? Journal of Infectious Diseases 1994, 170: 1041.

    PubMed  Google Scholar 

  7. Delforge ML, Liesnard C, Debaisieux M, Tchetcheroff M, Farber CM, Van Vooren JP: In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine. AIDS 1995, 9: 89–101.

    PubMed  Google Scholar 

  8. Schellekens PTA, Tersmette M, Roos MTL, Keet RP, de Wolf F, Coutinho RA, Miedema F: Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype. AIDS 1992, 6: 665–669.

    PubMed  Google Scholar 

  9. Richman DD, Bozzette SA: The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. Journal of Infectious Diseases 1994, 169:968–974.

    PubMed  Google Scholar 

  10. Karlsson A, Parsmyr K, Sandström E, Fenyö EM, Albert J: MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. Journal of Clinical Microbiology 1994, 32: 364–370.

    PubMed  Google Scholar 

  11. Koot M, Vos AHV, Keet RPM, Goede REY, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, Tersmette M: HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49–54.

    PubMed  Google Scholar 

  12. Karlsson A, Parsmyr K, Aperia K, Sandström E, Fenyö EM, Albert J: MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance. Journal of Infectious Diseases 1994, 170: 1367–1375.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Torres, Y., Leal, M., Rey, C. et al. Acquisition of syncytium-inducing HIV-1 strains during therapy with zidovudine alone or combined with alpha interferon or didanosine. Eur. J. Clin. Microbiol. Infect. Dis. 15, 324–327 (1996). https://doi.org/10.1007/BF01695665

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695665

Keywords

Navigation